Jane Street’s Cogent Biosciences COGT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-123,822
| Closed | -$742K | – | 5575 |
|
|
2025
Q1 | $742K | Buy |
123,822
+49,338
| +66% | +$296K | ﹤0.01% | 3425 |
|
|
2024
Q4 | $581K | Sell |
74,484
-37,379
| -33% | -$292K | ﹤0.01% | 3747 |
|
|
2024
Q3 | $1.21M | Sell |
111,863
-136,681
| -55% | -$1.48M | ﹤0.01% | 3126 |
|
|
2024
Q2 | $2.1M | Buy |
248,544
+203,822
| +456% | +$1.72M | ﹤0.01% | 2674 |
|
|
2024
Q1 | $301K | Buy |
44,722
+10,051
| +29% | +$67.5K | ﹤0.01% | 4631 |
|
|
2023
Q4 | $204K | Buy |
34,671
+5,024
| +17% | +$29.5K | ﹤0.01% | 4994 |
|
|
2023
Q3 | $289K | Sell |
29,647
-25,267
| -46% | -$246K | ﹤0.01% | 4096 |
|
|
2023
Q2 | $650K | Sell |
54,914
-12,674
| -19% | -$150K | ﹤0.01% | 3496 |
|
|
2023
Q1 | $729K | Buy |
+67,588
| New | +$729K | ﹤0.01% | 3231 |
|
|
2022
Q4 | – | Sell |
-28,506
| Closed | -$425K | – | 5591 |
|
|
2022
Q3 | $425K | Buy |
+28,506
| New | +$425K | ﹤0.01% | 3789 |
|
|
2022
Q2 | – | Hold |
0
| – | – | – | 5615 |
|
|
2021
Q3 | – | Sell |
-24,192
| Closed | -$196K | – | 5255 |
|
|
2021
Q2 | $196K | Buy |
+24,192
| New | +$196K | ﹤0.01% | 4455 |
|
|
2019
Q3 | – | Sell |
-12,583
| Closed | -$132K | – | 3481 |
|
|
2019
Q2 | $132K | Buy |
+12,583
| New | +$132K | ﹤0.01% | 3220 |
|
|
2018
Q4 | – | Sell |
-3,630
| Closed | -$150K | – | 3286 |
|
|
2018
Q3 | $150K | Buy |
+3,630
| New | +$150K | ﹤0.01% | 3203 |
|